N-methylation of ε-nitrogen of Lys 3 . Resin-bound peptide (350 mg, 0.14 mmol) was taken up into a 6 mL polypropylene cartridge with a polyethylene frit. The resin was immersed in 5 mL of THF. Separately triphenylphosphine (114 mg, 0.7 mmol) was dissolved in minimal THF and methanol (60 µL, 1.4 mmol) was added. This solution was then added to the resin. DIAD (138 µL, 0.7 mmol) was added dropwise with agitation. The reaction was agitated at RT for 15 minutes, and then washed with 3x5 mL of THF, 3x5 mL DMF, and 3x5 mL DCM. 
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mL polypropylene cartridge with a polyethylene frit. The resin was immersed in 5 mL of NMP, BME (99 µL, 1.4 mmol) and DBU (105 µL, 0.7 mmol) were added. The reaction was agitated at RT for 30 minutes. The resin was washed with 3x5 mL NMP and 3x5 mL DCM. 
On-resin reduction of Asp(OMe) side chain. A 250 mL round-bottom flask was charged with the peptide-bound resin (1g, 0.4 mmol) which was submersed in 20 mL of 1:1 EtOH:THF. To the suspension NaBH 4 (75.6 mg, 2 mmol) dissolved in minimal 1:1 EtOH:THF. The suspension was stirred magnetically at RT for 24 h. The reaction was quenched with 30 mL of methanol and the resin was filtered and washed with 3x30 mL THF.
On-resin oxidation of homoserine side chain. A 250 mL round-bottom flask was charged with the peptide-bound resin (1g, 0.4 mmol) which was submersed in 20 mL of DMSO. To the suspension was added 2-iodoxybenzoic acid (448 mg, 1.6 mmol) dissolved in minimal DMSO.
The suspension was stirred at RT for 4-18 h. The resin was filtered and washed 3x30 mL DMSO and 3x30 DCM. On-resin reductive amination. Peptide-bound resin (0.5 g, 0.2 mmol) was added to a polypropylene reaction vessel and swelled in 3 mL of DMF. To the suspension the 2 molar eq of secondary amine (piperidine or morpholine) was added. Following brief mixing, NaBH 3 CN (25 mg, 0.4 mmol) dissolved in minimal DMF was added and the reaction was agitated at RT for 3 hrs. The reaction was then quenched with methanol and the resin was filtered, washed with 3x5 mL of DMF and 3x5 mL of DCM. In vitro metabolism studies RRCK cell permeability. Cell permeability was determined using RRCK cells (Pfizer, Inc.
Groton, CT) 1 was used in B compartment. Protease inhibitor was added to both pH 6.5 and 7.4 HBSS at a ratio of 400 µL per 100 mL of buffer. These buffers are referred as "modified 6.5 HBSS" and "modified 7.4 HBSS". Starting compound solutions were made from 10mM DMSO stock solution diluted to 10 µM in modified pH 6.5 HBSS. Silanized glass tubes were used for stock solutions to limit non-specific binding.
Experiments were initiated by removing the cell culture medium from the apical and basolateral sides of the cell monolayers. Then 0.3 mL of modified pH 6.5 HBSS was placed in the A compartment and 1.0 mL of modified pH 7.4 HBSS was placed in the B compartment, and the monolayers were preincubated for 15 min at 37°C . After 15 min, HBSS was removed from both compartments. To conduct an A→B assay, 0.3 mL of compound solution in modified pH Chromatography was performed on a Phenomenex Synergy RP column, 150 × 4.6 mm, 5 µm (Phenomenex, Torrance, CA). LC analysis was performed at a constant flow rate of 1 mL/min using a binary solvent system: solvent A, 5 mM ammonium formate buffer (pH ~ 3.0) with 0.1% formic acid and solvent B, acetonitrile. The initial HPLC gradient system was held at 5% solvent B for 3 min and linearly increased to 80% solvent B in 35 min, followed by a return to initial conditions for column re-equilibration. Post-column flow passed through the PDA detector to provide UV (λ= 258 nm) detection prior to being split to the mass spectrometer such that mobile phase was introduced into the electrospray source at a rate of 50 µL/min. The LC 
